High-Dose Naloxone Formulations Are Not as Essential as We Thought.  Lemen PM, Garrett DP, Thompson E, Aho M, Vasquez C, Park JN.  medRxiv [Preprint]. 2023 Aug 14:2023.08.07.23293781. doi: 10.1101/2023.08.07.23293781. PMID: 37645849; PMCID…

Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients.  Amaducci A, Aldy K, Campleman SL, Li S, Meyn A, Abston S, Culbreth RE, Krotulski A, Logan B, Wax P, Brent J, Manini AF; Toxicology Investigators Conso…

Naloxone Guidance Development Group. Guidance on take-home naloxone distribution and use by community overdose responders in Canada.  Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choi…

The Double-Edged Sword: Naloxone-Induced Noncardiogenic Pulmonary Edema.  Marsalisi C, Guo HJ, Reddy P.  Cureus. 2023 Jul 10;15(7):e41642. doi: 10.7759/cureus.41642. PMID: 37575849; PMCID: PMC10412747. https://www.ncbi.nlm.nih.gov/pmc/arti…

Evaluation of a large-scale health department naloxone distribution program: Per capita naloxone distribution and overdose morality.  Freiermuth CE, Ancona RM, Brown JL, Punches BE, Ryan SA, Ingram T, et al. (2023)  PLoS ONE 18(8): e028995…

How to save a life: Public awareness of a national mass media take home naloxone campaign, and effects of exposure to campaign components on overdose knowledge and responses.  Sumnall HR, Atkinson AM, Anderson M, McAuley A, Trayner K.  Int…